Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1A dietary supplement is adulterated under section 402(f)(1)(B) of the Act (21 U.S.C. 342(f)(1)(B)) if it contains a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury. Based on our evaluation of the relevant safety evidence, there is inadequate information to provide reasonable assurance that *Amanita muscaria* does not present a significant or unreasonable risk of illness or injury. Therefore, your dietary supplements containing *Amanita muscaria* are adulterated under section 402(f)(1)(B) of the Act.
Passage 2There is no food additive regulation that authorizes the use of *Amanita muscaria*. We are not aware of any information to indicate that *Amanita muscaria* is the subject of a prior sanction (see 21 CFR Part 181). Furthermore, we are not aware of any basis to conclude that *Amanita muscaria* is GRAS for use in conventional foods. FDA's regulations in 21 CFR 170.30(a)-(c) describe the criteria for eligibility for classification of a food ingredient as GRAS. The use of a food substance may be GRAS based on either scientific procedures or, for a substance used in food before 1958, through experience based on common use in food (see 21 CFR 170.30).
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 170.30
- 21 CFR 170.30(a)
- 21 CFR 181